Incidence of end-stage renal disease in overseas-born, compared with Australian-born, non-indigenous Australians
- 1 August 2004
- journal article
- research article
- Published by Wiley in Nephrology
- Vol. 9 (4) , 247-252
- https://doi.org/10.1111/j.1440-1797.2004.00258.x
Abstract
BACKGROUND: Barriers to immigration from non-European sources were relaxed in the 1970s. As a result, more Australians are now of Middle Eastern, Asian or Pacific Islander origin, rather than British or European. Currently, overseas-born persons comprise one-third of non-indigenous Australians with end-stage renal disease (ESRD). METHODS: Using data recorded by the Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, age-standardized incidence rates were calculated for ESRD due to all causes and to certain primary renal diseases for all non-indigenous Australians who were aged over 15 years when first treated for ESRD between 1993 and 2001. Truncated age-standardized incidence rates were calculated for ESRD due to glomerulonephritis by type. RESULTS: Immigrants from the British Isles and 'rest of Europe' had less, and those from the Pacific Island nations, East/South-East Asia, Indian subcontinent, Middle East and Southern Europe more ESRD from all causes than the Australian-born. Two diseases accounted for most of the excess: Type 2 diabetic nephropathy and glomerulonephritis (the latter not significant for the Indian-born). There was a small excess (not always significant) of hypertensive/arteriopathic renal disease in Asian- and Middle Eastern-born persons. The East/South-East Asian-born had the highest rates of ESRD due to mesangial immunoglobulin A (IgA) disease and lupus nephritis, and the Middle Eastern-born the highest rates from focal sclerosing glomerulonephritis. CONCLUSION: For Australians born in the Pacific Island nations, Asia, the Middle East or Southern Europe, excess prevalence of, and/or susceptibility to, diseases that cause ESRD has more than offset any 'healthy migrant' effectKeywords
This publication has 13 references indexed in Scilit:
- The incidence of treated end-stage renal disease in New Zealand Maori and Pacific Island people and in Indigenous AustraliansNephrology Dialysis Transplantation, 2004
- Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999Nephrology Dialysis Transplantation, 2003
- Social disadvantage and variation in the incidence of end‐stage renal disease in Australian capital citiesAustralian and New Zealand Journal of Public Health, 2001
- The health of overseas-born Australians, 1994-1996.Australian Health Review, 1998
- The need and demand for renal replacement therapy in ethnic minorities in England.Journal of Epidemiology and Community Health, 1996
- Studying the causes of kidney disease in humans: A review of methodologic obstacles and possible solutionsAmerican Journal of Kidney Diseases, 1995
- Validation of the Cause of Renal Failure of Patients in the Medicare End-Stage Renal Disease ProgramAmerican Journal of Kidney Diseases, 1991
- A retrospective analysis of the natural history of primary IgA nephropathy worldwideThe American Journal of Medicine, 1990
- EXCESS INCIDENCE OF TREATMENT OF END-STAGE RENAL DISEASE IN MEXICAN AMERICANSAmerican Journal of Epidemiology, 1988
- Racial Differences in the Incidence of Treatment for End-Stage Renal DiseaseNew England Journal of Medicine, 1982